Home » Biodegradable Stents Market

Biodegradable Stents Market By Product (Coronary Stents, Peripheral Stents), By Material (Polymer, Metal) – Growth, Share, Opportunities & Competitive Analysis, 2017 – 2025

Price: $4999

Published: | Report ID: 3146 | Report Format : PDF

Market Insights

The report titled “Biodegradable Stents Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025” offers strategic insights into the overall biodegradable stents market, along with the market’s size and estimates for the duration of 2015–2025. The said research study covers an in-depth analysis of multiple market segments based on types of products, materials, and different geographies. A key estimate for interventional cardiology discussed by Transcatheter Cardiovascular Therapeutics (TCT) and the American College of Cardiology (ACC) in a meeting is that biodegradable stents will eventually replace conventional metallic stents in the near future. The rising prevalence of coronary artery disease, rising obesity due to sedentary lifestyles in the young population, and cardiologists’ increasing preference for biodegradable stents are the key factors assisting the growth of the biodegradable stent market.

For the purpose of this study, the global market for biodegradable stents is segmented on the basis of material type into polymer and metal. The product segment comprises the market for coronary and peripheral stents. Market size estimates and forecasts for these segments for the period 2015–2025 are provided in terms of USD million, along with the respective compounded annual growth rates (CAGRs) for the period 2017–2025, considering 2016 as the base year.

The geographical segmentation of the biodegradable stents market comprised regions such as North America, Europe, Asia-Pacific, Latin America & the Middle East, and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and GCC countries. The market size and forecast for these segments during 2015–2025 and their CAGRs for the period 2017–2025 are provided in this report.

The biodegradable stents market is observed as the most diversified and competitive market, comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Abbott Laboratories, Arterius Ltd., Boston Scientific, Inc., Biotronik, Kyoto Medical Corporation, Elixir Medical Corporation, Biosensors International, Terumo Europe NV, Ella CS, Arterial Remodeling Technologies SA, SMT (part of the Sahajanand Group of Companies), and others.

Based on the type of material, the global biodegradable stents market is segmented as follows:

  • Polymer
  • Metal

In 2016, polymer-based biodegradable stents accounted for the largest market share due to key driving factors such as the risks associated with metal-based biodegradable stents, reduced target vessel revascularization (TVR), long-term safety, and reduced risk of stent thrombosis and myocardial infarction. The most competent stents available in the market are the zotarolimus-eluting stent (Resolute, Medtronic), the cobalt-chromium everolimus-eluting stent (Xience, Abbott Vascular), and the platinum-chromium everolimus-eluting stent (Promus, Boston Scientific). According to market experts, clinical research has shown that resorbable stents offer a comparable efficacy and safety profile to drug-eluting stents. Thus, the global prevalence of coronary artery disease, cardiologists’ increasing preference for percutaneous coronary intervention procedures, and the increasing use of stents are expected to contribute significantly to this segment’s soaring revenue during the forecast period.

Based on the type of product, the global biodegradable stents market is segmented as follows:

  • Coronary Stents
  • Peripheral Stents

The coronary stents segment accounted for the largest share in 2016 due to key driving factors such as the rising prevalence of coronary artery diseases worldwide, increasing cardiologists’ preference for percutaneous coronary intervention procedures, increasing awareness associated with early diagnosis of cardiac diseases, and increased application of stents. According to World Health Organization (WHO) estimates, around 17.3 million people died from cardiovascular diseases in 2008, and it is expected that each year more than 23.3 million people will die due to cardiovascular diseases; this trend is predicted to continue until 2030. However, the Centers for Disease Control and Prevention (CDC) in the U.S. suggested that the number of deaths due to coronary artery diseases has started decreasing due to an increase in the number of percutaneous coronary interventions being performed by using a range of coronary stents available in the global market.

For the purpose of this study, the global biodegradable stents market is categorized into three segments:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In the base year 2016, Europe accounted for the largest market share due to key drivers such as increasing public awareness related to early disease diagnosis, increasing obesity in the geriatric population, and easy access to modern medical facilities. According to the Europe Heart Network, each year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). Hospital discharge rates for CVD as a whole have increased steadily in Europe over the past 25 years. During the forecast period of 2017–2025, Asia-Pacific was observed as the fastest growing biodegradable stents market due to key drivers such as premium pricing for life-essential devices, push strategy approaches by key players to penetrate the market, India being the largest market in Asia-Pacific with a huge population, and rising healthcare expenditure assisted by mounting economic growth.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Biodegradable Stents Market Portraiture
2.2 Global Biodegradable Stents Market Share, by Product, 2016 Vs 2025 (Value %)
2.3 Global Biodegradable Stents Market, by Type of Material, 2016 Vs 2025 (Value %)
2.4 Global Biodegradable Stents Market, by Geography, 2016 (Value %)

Chapter 3 Global Biodegradable Stents Market Analysis
3.1 Global Biodegradable Stents Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Aging population assisting the growth of cardiovascular surgeries due to increased risk of coronary and peripheral artery diseases
3.2.1.2 Rising demand for safe and minimally invasive treatments
3.2.1.3 Recent product approvals and rising applications of biodegradable stents in several disease conditions
3.2.2 Challenges
3.2.2.1 Laser angioplasty and alternative non-invasive procedures are gaining popularity and preferences in many developed and developing regions
3.2.2.1 Biodegradable stent implant still possess risks such as persistent rate of restenosis and stent thrombosis
3.2.3 Opportunities
3.2.3.1 Strong pipeline is expected to provide innovative biodegradable stents equipped with high safety and efficacy
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Market Positioning of Key Players in Biodegradable Stents Market

Chapter 4 Global Biodegradable Stents Market Analysis, by Product
4.1 Introduction
4.2 Coronary Stents
4.3 Peripheral Stents

Chapter 5 Biodegradable Stents Market Analysis, by Material
5.1 Introduction
5.2 Polymer
5.3 Metal

Chapter 6 Global Biodegradable Stents Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan, and Rest of APAC)
6.5 Latin America (Brazil, Mexico, & Rest of Latin America)
6.6 Middle East and Africa (Saudi Arabia, South Africa, & Rest of the Middle East and Africa)

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.2 Arterius Ltd.
7.3 Boston Scientific, Inc.
7.4 Biotronik
7.5 Kyoto Medical Corporation
7.6 Elixir Medical Corporation
7.7 Biosensors International
7.8 Terumo Europe NV
7.9 Ella CS
7.10 Arterial Remodeling Technologies SA
7.11 SMT (Part of Sahajanand Group of Companies)

List of Figures

FIG. 1 Global Biodegradable Stents Market: Research Methodology
FIG. 2 Global Biodegradable Stents Market Share, by Product, 2016 Vs 2025 (Value %)
FIG. 3 Global Biodegradable Stents Market, by Type of Material, 2016 Vs 2025 (Value %)
FIG. 4 Global Biodegradable Stents Market, by Geography, 2016 (Value %)
FIG. 5 Attractive Investment Proposition: Global Biodegradable Stents Market, by Geography
FIG. 6 Competitive Analysis: Market Positioning of Key Players in Global Biodegradable Stents Market
FIG. 7 Global Biodegradable Coronary Stents Market, 2015 – 2025 (US$ Mn )
FIG. 8 Global Biodegradable Peripheral Stents Market, 2015 – 2025 (US$ Mn )
FIG. 9 Global Polymer-based Biodegradable Stent Market , 2015 – 2025 (US$ Mn)
FIG. 10 Global Metal-based Biodegradable Stent Market , 2015 – 2025 (US$ Mn)
FIG. 11 Latin America Biodegradable Stents Market, 2015 – 2025 (US$ Mn)
FIG. 12 Middle East & Africa Biodegradable Stents Market, 2015 – 2025 (USD Mn)

List of Tables

TABLE 1 Global Biodegradable Stents Market, By Product 2015-2025 (US$ Mn)
TABLE 2 Global Biodegradable Stents Market, by Material, 2015-2025 (US$ Mn)
TABLE 3 Global Biodegradable Stents Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 4 North America Biodegradable Stents Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Biodegradable Stents Market, by Country, 2015 – 2025 (USD Mn)
TABLE 6 Asia-Pacific Biodegradable Stents Market, by Country, 2015 – 2025 (USD Mn)
TABLE 7 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 8 Arterius Ltd.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 9 Boston Scientific, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 10 Biotronik: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 11 Kyoto Medical Corporation: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 12 Elixir Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Biosensors International: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Terumo Europe NV: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 15 Ella CS: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Arterial Remodeling Technologies SA: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 SMT (Part of Sahajanand Group of Companies): Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Biodegradable Stents Market?

The market for Biodegradable Stents Market is expected to reach USD 6,310.5 Mn By 2025.

What is the Biodegradable Stents Market CAGR?

The Biodegradable Stents Market is expected to see significant CAGR growth over the coming years, at 29.5%.

What is the Forecast period considered for Biodegradable Stents Market?

The report is forecasted from 2017-2025.

What is the base year considered for Biodegradable Stents Market?

The base year of this report is 2016.

Who are the major players in this market?

Biotronik, Kyoto Medical Corporation, Elixir Medical Corporation, Biosensors International, Terumo Europe NV, Ella CS, Arterial Remodeling Technologies SA, SMT (part of the Sahajanand Group of Companies) are some of the major players in the global market.

Glycated Albumin Assay Market

Published:
Report ID: 33574

Proliferative Diabetic Retinopathy Market

Published:
Report ID: 33536

Endoscopic Ultrasound (EUS) Needles Market

Published:
Report ID: 4131

Healthcare POS Terminals Market

Published:
Report ID: 13903

Optogenetics Market

Published:
Report ID: 8143

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Venous Thromboembolism (VTE) Treatment Market

Published:
Report ID: 11666

X-Ray Equipment Market

Published:
Report ID: 9306

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN